Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Literature
1.
Wada Y, Ogata H, Takeshige Y, Takeshima A, Yoshida N, Yamamoto M, et al. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol. 2013;17(1):73–82.PubMedCentralPubMedCrossRef
2.
Nasri H. IgG deposition in IgA nephropathy patients. J Ren Inj Prev. 2012;2(1):11–3.
3.
Mubarak M. Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: the need for more validation studies. J Nephropathol. 2013;2(3):210–3.PubMedCentralPubMed
4.
Bellur SS, Troyanov S, Cook HT, Roberts IS. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 2011;26(8):2533–6.PubMedCrossRef
5.
Nasri H, Sajjadieh S, Mardani S, momeni A, Merikhi A, Madihi Y, et al. Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy. J Nephropathol. 2013;2:190–5.PubMedCentralPubMed
Metadata
Title
Comment on: Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
Authors
Azar Baradaran
Hamid Nasri
Publication date
01-02-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0890-9

Other articles of this Issue 1/2014

Clinical and Experimental Nephrology 1/2014 Go to the issue

Original Article

Urinary and glomerular podocytes in patients with chronic kidney diseases

Commentary

Membranoproliferative glomerulonephritis: the times they are a-changin’

Letter to the Editor

Is calcium replacement therapy unnecessary for severe hypocalcemia associated with rhabdomyolysis?

Erratum

Erratum to: U-shaped association between body mass index and proteinuria in a large Japanese general population sample

Original Article

Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood

Original Article

Prevalence of renal disease within an urban HIV-infected cohort in northern Italy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits